Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor‐associated macrophages

BACKGROUND: Patients with combined hepatocellular‐cholangiocarcinoma (cHCC‐CCA) have limited treatment options and poor prognosis. Tumor‐associated macrophages (TAMs) are the most abundant infiltrating immune cells in the tumor microenvironment and promote tumor stemness, proliferation, invasion and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Kun, Lin, Junqing, Huang, Ning, Yan, Leye, Liao, Rihua, Yang, Weizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598247/
https://www.ncbi.nlm.nih.gov/pubmed/37688511
http://dx.doi.org/10.1002/cnr2.1888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598247/
https://www.ncbi.nlm.nih.gov/pubmed/37688511
http://dx.doi.org/10.1002/cnr2.1888

Ejemplares similares